Bridgebio Pharma Inc (BBIO)

CapEx to Revenue

0.18%

Quarterly · Period ending:

BBIO logo

BBIO CapEx to Revenue

Latest reported0.18%
BBIO Quarterly CapEx/Revenue (0.00% → 0.18%)
High-resolution chart · PNG

BBIO capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0.1818%
0.0355%
2.9401%
0.3894%
4.6072%
1.3675%
55.0323%
63.3968%
112.869%
0.7067%
24.9284%
10.5353%
26.0817%
0.6572%
42.8342%
224.5562%
5.2911%
50.7084%
19.6803%
1,768.8567%
4.2333%
424.4589%
1,759.0164%
6.7553%
0%
0%
12.642%
1.4248%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.